Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next...
Read More
With modern and advanced varieties of central laboratory proposals, a more thoughtful test selection process is needed. The importance of Central Lab and its approach creates a real partnership between the central laboratory and the test sponsor, adding value and helping to speed up the journey from molecule to the clinic.As...
Read More
Pharma giant Gilead’s antiviral drug Remdesivir has won US regulatory approval for emergency use in patients that are severely ill from Covid-19. Minister of Health and Family Welfare Harsh Vardhan has said India is part of World Health Organisation’s (WHO) solidarity trials to combat coronavirus and has received 1,000...
Read More
Gilead Sciences has said that its antiviral drug, Remdesivir, will be available to patients as early as this week, Gilead Science CEO Daniel O’Day told American television channel CBS. “We intend to get that to patients in the early part of this next week, beginning to work with the government...
Read More
Japanese company Fujifilm has launched a Phase II clinical trial of its influenza drug Avigan (favipiravir) to treat Covid-19 patients in the US. Approved in 2014 in Japan, Avigan specifically targets RNA polymerase required for influenza virus replication. This mechanism is also expected to have an antiviral effect on...
Read More
